Concepedia

Mark A. Dominick

MA

Statistics

Publications

25

Citations

978

H-Index

18

Active since

1983

Affiliations

Bristol-Myers Squibb (United States)(Current)

National Animal Disease Center

University of Nebraska Medical Center

Bristol-Myers Squibb (Germany)

Warde Medical Laboratory

Mark A. Dominick is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and toxicology.

Publications per year

1983–2011

25

Publications

25

An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing

Frank D. Sistare, Daniel Morton, Carl L. Alden et al. · Toxicologic Pathology · 2011 · 152 citations · Full text

, , +17

Ketamine prevents ischemic neuronal injury

F Marcoux, James E. Goodrich, Mark A. Dominick · Brain Research · 1988 · 99 citations

, , +11

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action

Mark A. Dominick, Melvin R. White, Thomas P. Sanderson et al. · Toxicologic Pathology · 2006 · 92 citations · Full text

, , +13

Subacute Toxicity of a Novel Inhibitor of Acyl-CoA: Cholesterol Acyltransferase in Beagle Dogs

Mark A. Dominick · Fundamental and Applied Toxicology · 1993 · 65 citations

, , +13

Morphogenesis of a Zone-Specific Adrenocortical Cytotoxicity in Guinea Pigs Administered PD 132301-2, an Inhibitor of Acyl-CoA: Cholesterol Acyltransferase

Mark A. Dominick, Walter A. Bobrowski, John R. MacDonald et al. · Toxicologic Pathology · 1993 · 54 citations · Full text

, , +14

1–5 of 25